ARCHIVES

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 7 | July 25, 2008

Download PDF Visit The Full Archive

Related Articles

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

MSKCC Gets $100 Million Commitment From Mortimer Zuckerman For New Research Building.

May 12, 2006

PhRMA Tightens DTC Restrictions, But Dingell Says It’s Not Enough.

December 12, 2008

New Therapies Could Benefit Patients With Difficult Cancers

June 25, 2010

Investigation finds no evidence FDA’s Crawford had affair with subordinate.

June 10, 2005

Wanted: Methods To Measure Or Estimate Renal Function For Dosing Cancer Drugs

October 15, 2010